-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Adhera Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- Adhera Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$3.27M, a 160% decline year-over-year.
- Adhera Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$3.21M, a 61.2% decline year-over-year.
- Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$496K, a 91.3% increase from 2021.
- Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$5.68M, a 228% decline from 2020.
- Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.73M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)